1st Quarter - Report

JENNINGS POLICY STRATEGIES for GENERIC PHARMACEUTICAL ASSOCIATION

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1427, S. 726, HR 3200, HR 3495 and H.R. 1548).

LobbyistCovered position, as disclosed
CHRISTOPHER JENNINGS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3495 (111th), H.R. 1427 (111th), H.R. 1548 (111th), S. 726 (111th), H.R. 3200 (111th)

Health Issues HCR

Advocate for cost containment policies, including generic access and the removal of barriers to greater competition in the pharmaceutical marketplace (including but not limited to H.R. 1427, S. 726, HR 3200, HR 3495 and H.R. 1548).

LobbyistCovered position, as disclosed
CHRISTOPHER JENNINGS —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 726 (111th), H.R. 3200 (111th), H.R. 1427 (111th), H.R. 1548 (111th), H.R. 3495 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.